Although the hemagglutination inhibition (HAI) test is the standard assay for detecting antibodies against influenza A and B viruses, in some instances it does not detect antibody increases in patients naturally infected with influenza viruses. This may be due to the antigenic drift manifested by influenza A viruses from year to year, so that use of standardized hemagglutinin reagents may not detect antibody after infection with heterologous influenza A viruses (3, 7, 8, 18 ). In the case of influenza B virus, less frequent and less extensive antigenic changes occur (16, 17) , yet not all infected persons develop HAI antibody increases. Recently, enzyme-linked immunosorbent assays (ELISA) utilizing various antigen preparations of influenza viruses have been developed for the detection of antibodies to influenza A or B viruses (2, 4, 5, 8, 9, 11, 12 The ELISA was modified from the procedure of Murphy et al. (12) . The optimal dilutions of each antigen were determined by checkerboard titration in carbonate buffer. The optimum dilutions corresponded to 13 to 32 hemagglutinating units of influenza B virus per microtiter well. Viral antigen and control antigen was adsorbed to flat-bottom, 96-well microtiter plates (micro-ELISA M129A; Dynatech Laboratories, Inc., Alexandria, Va.) for a minimum of 18 h at 4°C before use. After washing three times with phosphate-buffered saline, sera in fourfold dilutions, 1:100 to 1:25,600, were then added to duplicate wells. Dilutions of sera less than 1:100 frequently manifested reactivity with control antigens, and therefore they were not tested (14) . After 18 h of incubation at 4°C, the excess serum was washed from each well, the optimal dilution of alkaline phosphatase conjugated anti-human immunoglobulin G prepared in goats (Miles Laboratories, Elkhart, Ind.) was added, and the plates were incubated at 35°C for 2 h. After washing to remove excess conjugate, substrate (p-nitrophenyl phosphate; Sigma 104; Sigma Chemical Co., St. Louis, Mo.), diluted to 1 mg/ml in diethanolamine buffer, was added. After 30 min of incubation at 37°C, the absorbance (405 nm) of each well was determined by an automated reader (Multiskan; Flow Laboratories, McLean, Va.).
A single reference serum, in fourfold dilutions of 1:100 to 1:25,600, was included in each group of tests as a standard. This reference serum has been used many times in our laboratory with the antibody titer set at 1:1,600. The 1:1,600 dilution was considered the endpoint since this dilution had an absorbance value of approximately 0.40, whereas the absorbance value of the serum at 1:6,400 dilution was less that 0.10. The reference serum, at a 1:1,600 dilution, was included on each plate to monitor the development of the enzyme reaction.
The antibody titer for each test serum was calculated as follows. A calibration line was fitted by least squares to a series of log dilutions and the corresponding logit absorbances of the reference serum. The fitted logit absorbance, designated y*, of the preselected dilution (1:1,600) was derived from the slope and intercept of the calibration line. For each experimental serum, a line was fitted by least squares to a series of log dilutions and the corresponding logit absorbances. The titer of the experimental serum was taken to be the antilog of the fitted log dilution on the line in question which corresponded to y*. Fourfold or greater rises in ELISA titers between acute and convalescent sera were considered diagnostic of infection.
HAI procedure. The HAI procedure was that of the WHO Influenza Center (19) . The initial serum dilution used was 1:10. The antigens used in the ELISA and HAI are summarized in Table 1 
RESULTS
The reproducibility of the ELISA antibody titers was evaluated by testing three sera 10 times each. The logl0 mean titers of the three sera with the B/WV-tc antigen were 3.1, 2.9, and 4.1, and the corresponding coefficients of variation were 3.2, 3.4, and 7.3%, respectively. The logl0 mean titers using the B/HK-tc antigen were 3.2, 2.9, and 4.0, and the corresponding coefficients of variation were 6.3, 3.9, and 2.5%, respectively. There was less than a threefold difference in titer in replicate determinations comparing the maximum and minimum values obtained at any time for any of the three sera tested.
Using the BIWV-tc antigen we compared the ELISA titer with the HAI titer in sera from adults and children (Fig. 1) . There was good correlation between the log HAI and log ELISA titers (r = 0.71, P < 0.01). Nine sera (all from children) were antibody free as indicated by both ELISA and HAI. Only one serum contained antibody that was detected by HAI, but not by ELISA. In contrast, 15 sera had ELISA antibody, but did not have HAI antibody. ELISA detected antibody significantly more often than did HAI (X2 = 6.9; P < 0.01).
We compared the sensitivity of ELISA to that of HAI for the detection of fourfold antibody increases among adults and children infected with influenza B virus ( 15 of 21, x2 < 1, P = not significant).
We also evaluated the specificity of the B/ WV-tc ELISA by testing paired sera from children infected with other respiratory viruses (Table 2). Sera from six patients infected with parainfluenza 1, four patients infected with parainfluenza 2, two patients infected with parainfluenza 3, five patients infected with adenovirus, six patients infected with respiratory syncytial virus, and five patients infected with influenza A virus were tested by ELISA. None (20) . Others also have found that children and young adults have not demonstrated good antibody responses to primary infection with influenza viruses. None of the children who failed to manifest an ELISA antibody response had detectable ELISA antibody (ELISA titer <50) before or after infection with influenza B virus (7, 18 ). An immunoglobulin M antibody response was the principal response that occurred in children who lacked prior experience with influenza A/H1Nj surface antigens (11) . However, using an influenza B whole virus antigen which was more purified than ours, Murphy et al. were able to detect immunoglobulin G antibody rises in 10 of 10 children with influenza B virus infection (12) . A more purified antigen may be necessary to measure small amounts of influenza B virus antibody in children, since lower dilutions of sera can be used without giving cross-reactions with other antigens in the preparations, as occurs in our ELISA with unpurified whole virus.
Avidity between antibody and influenza B virus has been reported to be more important than the antigenic type of influenza B virus used in the HAI test, and ether treatment of virus has been used to increase avidity (10) . We also found that using different antigenic types of influenza B virus did not significantly alter the sensitivity of the HAI test or ELISA test. However, we found that uncloned tissue culturegrown antigens were superior to egg-grown antigens in the HAI test. Whether this phenomenon is due to the differing passage histories of the viruses or due to the cell system in which the virus was produced was not determined by these experiments. The ELISA described in this report used the whole virus and therefore contained the internal viral antigens as well as the surface antigens. Thus, this ELISA may not reflect a difference in serum antibody response to various hemagglutinins of influenza B virus. Similar enzyme immunoassays which use whole virus antigen preparations do not detect strainspecific antibody to influenza A virus. To detect strain-specific antibody to influenza A virus requires the use of purified hemagglutinin as the ELISA antigen (11). Murphy et al. have demonstrated that a hemagglutinin-specific ELISA was more sensitive than HAI in detecting antibody (11) , but the HAI used by Hammond et al. was more sensitive than a whole-virus enzyme immunoassay to detect antibody to influenza A virus (5) . Whether ELISA with purified influenza B virus hemagglutinin could detect antibody rises after primary infection of children remains an area for future investigation.
